Skip to main content

Research Repository

Advanced Search

Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis

Molica, Stefano; Allsup, David; Giannarelli, Diana

Authors

Stefano Molica

Diana Giannarelli



Citation

Molica, S., Allsup, D., & Giannarelli, D. (2024, December). Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis. Presented at American Society of Haematology, San Diego

Presentation Conference Type Conference Abstract
Conference Name American Society of Haematology
Start Date Dec 6, 2024
End Date Dec 10, 2024
Acceptance Date Nov 5, 2024
Online Publication Date Nov 5, 2024
Publication Date Nov 5, 2024
Deposit Date Dec 16, 2024
Publicly Available Date Nov 6, 2025
Journal Blood
Print ISSN 0006-4971
Publisher American Society of Hematology
Peer Reviewed Peer Reviewed
Volume 144
Issue Supplement 1
Pages 4630-4630
DOI https://doi.org/10.1182/blood-2024-200896
Public URL https://hull-repository.worktribe.com/output/4963939